Epigenetics in Cardiovascular Disease

    Epigenetics has been initially studied in patients with CVD for its prominent role in inflammation and vascular involvement Furthermore, epigenetic studies in cardiovascular medicine revealed a significant number of modifications affecting the development and progression of CVD.  Epigenomics are involved in cardiovascular risk factors such as smoking, diabetes, hypertension and age.

 

  • Cardiac hypertrophy
  • Heart failure
  • Arrhythmias

Related Conference of Epigenetics in Cardiovascular Disease

July 21-22, 2025

18th World Congress on Stem Cell Research

Barcelona, Spain
August 28-29, 2025

12th World Congress on Epigenetics and Chromosome

London, UK
September 16-17, 2025

5th Experts Meeting on Plant, Cellular and Molecular Biology

Madrid, Spain
September 25-26, 2025

18th World Congress on Advances in Stem Cell Research and Regenerative Medicine

Montreal, Canada
October 27-28, 2025

20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

Madrid, Spain
October 30-31, 2025

Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

Rome, Italy
November 17-18, 2025

18th International Conference on Human Genomics and Genomic Medicine

Paris, France
June 18-19, 2026

16th International Conference on Human Genetics and Genetic Diseases

Singapore City, Singapore
June 18-19, 2026

19th International Conference on Genomics & Pharmacogenomics

Singapore City, Singapore
September 25-26, 2025

6th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Epigenetics in Cardiovascular Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in